
Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation
Author(s) -
Byung-Sik Cho,
SeungAh Yahng,
SungEun Lee,
KiSeong Eom,
Yoo-Jin Kim,
Heeje Kim,
Seok Lee,
ChangKi Min,
Seok-Goo Cho,
Dong-Wook Kim,
JongWook Lee,
Woo-Sung Min,
Chong-Won Park
Publication year - 2010
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e3181f24e8d
Subject(s) - thrombotic microangiopathy , medicine , cumulative incidence , cohort , transplantation , hematopoietic stem cell transplantation , oncology , disease
The lack of an accepted definition of transplantation-associated thrombotic microangiopathy (TMA) has led the Blood and Marrow Transplants Clinical Trials Network (CTN) and International Working Group (IWG) to propose a definition for TMA with some differences. However, there have been few studies validating and comparing both newly proposed criteria for TMA.